masstortreport

Huge Win for Zofran Plaintiffs, Claims Proceed Closer to Jury Trial

Zofran Birth Defect Multi-District Litigation On February 5, 2019, the Massachusetts judge presiding over the Zofran (ondansetron) birth defect multi-district litigation rejected GlaxoSmithKline’s (GSK) motion for summary judgment based on preemption. U.S. District Judge F. Dennis Saylor IV said that questions remain about whether GSK fully disclosed key data to the FDA about the anti-nausea …. Read More

Contact Us
Web Analytics